The single use of body mass index for the obesity paradox is misleading and should be used in conjunction with other obesity indices

References

• Benjamin EJ, Blaha MJ, Chiuve SE, et al. American Heart Association statistics committee and stroke statistics subcommittee. Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation. 2017;135:e146–e603.
   PubMed Web of Science ®Google Scholar
• Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2014;384:766–781.
   PubMed Web of Science ®Google Scholar
• Qasim A, Turcotte M, de Souza RJ, et al. On the origin of obesity: identifying the biological, environmental and cultural drivers of genetic risk among human populations. Obesity Rev. 2018;19:121–149.
   PubMed Web of Science ®Google Scholar
• Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics- 2015 update: a report from the American Heart Association. Circulation. 2015;131:e29- e322.
   PubMed Web of Science ®Google Scholar
• Khan SS, Ning H, Wilkins JT, et al. Association of body mass index with lifetime risk of cardiovascular disease and compression of morbidity. JAMA Cardiol. 2018;3:280–287.
   PubMed Web of Science ®Google Scholar
• Fan J, Song Y, Chen Y, et al. Combined effect of obesity and cardiometabolic abnormality on the risk of cardiovascular disease: a meta-analysis of prospective cohort studies. Int J Cardiol. 2013;168:4761–4768.
   PubMed Web of Science ®Google Scholar
• Bell JA, Kivimaki M, Hamer M. Metabolically healthy obesity and risk of incident type 2 diabetes: a meta-analysis of prospective cohort studies. Obesity Rev. 2014;15:504–515.
   PubMed Web of Science ®Google Scholar
• Jensen MD, Ryan DH, Apovian CM, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obese adults. J Am Coll Cardiol. 2014;63:2985–3023.
   PubMed Web of Science ®Google Scholar
• Clark AL, Fonarow GC, Horwich TB. Waist circumference, body mass index, and survival in systolic heart failure: the obesity paradox revisited. J Heart Fail. 2011;17:374–380.
   Google Scholar
• Clark AL, Chyu J, Horwich TB. The obesity paradox in men versus women with systolic heart failure. Am J Cardiol. 2012;110:77–82.
   PubMed Web of Science ®Google Scholar
• Sharma A, Lavie CJ, Borer JS, et al. Meta-analysis of the relation of body mass index to all-cause and cardiovascular mortality and hospitalization in patients with chronic heart failure. Am J Cardiol. 2015;115:1428–1434.
   PubMed Web of Science ®Google Scholar
• Lin GM, Li YH, Yin WH, et al. The obesity-mortality paradox in patients with heart failure in Taiwan and a collaborative meta-analysis for East Asian patients. Am J Cardiol. 2016;118:1011–1018.
   PubMed Web of Science ®Google Scholar
• Wang ZJ, Zhou YJ, Galper BZ, et al. Association of body mass index with mortality and cardiovascular events for patients with coronary artery disease: a systemic review and meta-analysis. Heart. 2015;101:1631–1638.
   PubMed Web of Science ®Google Scholar
• Vest AR, Wu Y, Hachamovitch R, et al. The heart failure overweight/obesity survival paradox. J Am Coll Cardiol HF. 2015;3:917–926.
   Google Scholar
• Li YH, Lin GM, Lin CL, et al. Relation of body mass index to mortality with percutaneous coronary intervention longer than 5 years follow-up: a meta-analysis. Int J Cardiol. 2013;168:4315–4318.
   PubMed Web of Science ®Google Scholar
• Chrysant SG, Chrysant GS. New insights into the true nature of the obesity paradox and the lower cardiovascular risk. J Am Soc Hypertens. 2013;7:85–94.
   PubMed Web of Science ®Google Scholar
• Masters RK, Reither EN, Powers DA, et al. The impact of obesity on US mortality levels: the importance of age and cohort factors on population estimates. Am J Public Health. 2013;103:1895–1901.
   PubMed Web of Science ®Google Scholar
• Park DW, Kim YH, Yun SC, et al. Association of body mass index with major cardiovascular events and with mortality after percutaneous coronary intervention. Circ Cardiovasc Intrv. 2013;6:146–153.
   PubMed Web of Science ®Google Scholar
• Herrmann J, Gersh BJ, Goldfinger JZ, et al. Body mass index and acute and long-term outcomes after acute myocardial infarction (from the harmonizing outcomes with revascularization and stents in acute myocardial infarction trial). Am J Cardiol. 2014;114:9–16.
   PubMed Web of Science ®Google Scholar
• Niedziela J, Hudzik B, Niedziela N, et al. The obesity paradox in acute coronary syndrome: a meta-analysis. Eur J Epidemiol. 2014;29:801–812.
   PubMed Web of Science ®Google Scholar
• Sharma A, Vallakati A, Einstein AJ, et al. Relationship of body mass index with total mortality, cardiovascular mortality and myocardial infarction after coronary revascularization: evidence from a meta-analysis. Mayo Clin Proc. 2014;89:1080–1100.
   PubMed Web of Science ®Google Scholar
• Tan XF, Shi JX, Chen MH. Prolonged and intensive medication use is associated with the obesity paradox after percutaneous coronary intervention: a systematic review and meta-analysis of 12 studies. BMC Cardiovasc Dis. 2016;16:125.
   PubMed Web of Science ®Google Scholar
• Holroyd EW, Sirker A, Kwok CS, et al. The relationship of body mass index to percutaneous coronary intervention outcomes. J Am Coll Cardiol Invt. 2017;10:1283–1292.
   Web of Science ®Google Scholar
• Azhari Z, Ismail MD, Zuhdi AS, et al. Association between body mass index and outcomes after percutaneous coronary intervention in multiethnic South East Asian population: a retrospective analysis of the Malaysian National Cardiovascular Disease Database-Percutaneous Coronary Intervention (NCVD-PCI) registry. BMJ Open. 2017;7:e017794.
   PubMed Web of Science ®Google Scholar
• Moscarella E, Spitaleri G, Brugaletta S, et al. Impact of body mass index on 5-year clinical outcomes in patients with ST-segment elevation myocardial infarction after everolimus-eluting or bare-metal stent implantation. Am J Cardiol. 2017;120:1460–1466.
   PubMed Web of Science ®Google Scholar
• Matinrazm S, Ladejobi A, Pasupula DK, et al. Effect of body mass index on survival after sudden cardiac arrest. Cin Cardiol. 2018;41:46–50.
   Web of Science ®Google Scholar
• Takiguchi M, Yoshihisa A, Miura S, et al. Impact of body mass index on mortality in heart failure patients. Eur J Clin Inest. 2014;44:1197–1205.
   PubMed Web of Science ®Google Scholar
• Khalid U, Ather S, Bavishi C, et al. Pre-morbid body mass index and mortality after incident heart failure. The ARIC study. J Am Coll Cardiol. 2014;64:2743–2749.
   PubMed Web of Science ®Google Scholar
• Shah R, Gayat E, Januzzi jr JL, et al. Body mass index and mortality in acutely decompensated heart failure across the world. J Am Coll Cardiol. 2014;63:778–785.
   PubMed Web of Science ®Google Scholar
• Oga EA, Eselyn OR. The obesity paradox and heart failure: a systematic review of a decade of evidence. J Obes. 2016;2016:9040248.
   PubMed Web of Science ®Google Scholar
• Hong S, Lee JH, Kim KM, et al. Is there a sex-related difference in the obesity paradox in systolic heart failure? Sex-related difference in the obesity paradox. Yonsei Med J. 2018;59:57–62.
   PubMed Web of Science ®Google Scholar
• Chang VW, Langa KM, Weir D, et al. The obesity paradox and incident cardiovascular disease: a population-based study. PLOS One. 2017;12:e0188636.
   PubMed Web of Science ®Google Scholar
• Tsusjimoto T, Kajio H. Abdominal obesity is associated with increased risk of all-cause mortality in patients with HFpEF. J Am Coll Cardiol. 2017;70:2739–2749.
   PubMed Web of Science ®Google Scholar
• Lavie CJ, Milani RV, Ventura HO. Adipose composition and heart failure prognosis. Paradox or not? J Am Coll Cardiol. 2017;70:2750–2751.
   PubMed Web of Science ®Google Scholar
• Akin I, Tolg R, Hochadel M, et al. No evidence of “obesity paradox” after treatment with drug-eluting stents in a routine clinical practice. Results from the prospective multicenter German DES-DE (German drug-eluting stent) registry. J Am Coll Cardiol Intv. 2012;5:162–169.
   Web of Science ®Google Scholar
• Hallberg V, Kataja M, Lahtela J, et al. Obesity paradox disappears in coronary artery bypass graft patients during 20-year follow-up. Eu Heart J Acute Cardiovasc Care. 2017;6:771–777.
   PubMed Web of Science ®Google Scholar
• Flegal KM, Kit BK, Orpana H, et al. Association of all-cause mortality with overweight and obesity using standard body mass index categories. A systematic review and meta-analysis. JAMA. 2013;309:71–82.
   PubMed Web of Science ®Google Scholar
• Caleyachetty R, Thomas GN, Toulis KA, et al. Metabolically healthy obese and incident cardiovascular disease events among 3.5 million men and women. J Am Coll Cardiol. 2017;70:1429–1437.
   PubMed Web of Science ®Google Scholar
• Barrett-Connor E, Khaw KT. Is hypertension a more benign when associated with obesity? Circulation. 1985;72:53–60.
   PubMed Web of Science ®Google Scholar
• Uretsky S, Messerli FH, Bangalore S, et al. Obesity paradox in patients with hypertension and coronary artery disease. Am J Med. 2007;120:863–870.
   PubMed Web of Science ®Google Scholar
• Shah RV, Abbasi SA, Yarnal JM, et al. Impaired fasting glucose and body mass index as determinants of mortality in ALLHAT: is the obesity paradox real? J Clin Hypertens. 2014;16:451–458.
   Web of Science ®Google Scholar
• Jayedi A, Shab-Bidar S. Nonlinear dose-response association between body mass index and risk of all-cause and cardiovascular mortality in patients with hypertension: a meta-analysis. Obes Res Clin Pract. 2018;12:16–28.
   PubMed Web of Science ®Google Scholar
• Esler M, Lambert G, Schlaich M, et al. Obesity paradox in hypertension. Is this because sympathetic activation in obesity-hypertension takes a benign form? Hypertension. 2018;71:15–21.
   PubMed Web of Science ®Google Scholar
• Coutinho T, Goel K, de sa DC, et al. Central obesity and survival in subjects with coronary artery disease. J Am Coll Cardiol. 2011;57:1877–1886.
   PubMed Web of Science ®Google Scholar
• Lee CM, Huxley RR, Wildman RP, et al. Indices of abdominal obesity are better discriminators of cardiovascular risk factors than BMI: a meta-analysis. J Clin Epidemiol. 2008;61:646–653.
   PubMed Web of Science ®Google Scholar
• De Koning L, Merchant AT, Pogue J, et al. Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: a meta-regression analysis of prospective studies. Eur Heart J. 2007;28:850–856.
   PubMed Web of Science ®Google Scholar
• Horwich TB, Foranow GC, Clark A. Obesity and the obesity paradox in heart failure. Prog Cardiovasc Dis. 2018;61:151–156.
   PubMed Web of Science ®Google Scholar
• Lavie CJ, Laddu D, Arena R, et al. Healthy weight and obesity prevention. J Am Coll Cardiol. 2018;72:1506–1531.
   PubMed Web of Science ®Google Scholar
• Elagizi A, Kachur S, Lavie CJ, et al. An overview and update on obesity and the obesity paradox in cardiovascular diseases. Prog Cardiovasc Dis. 2018;61:142–150.
   PubMed Web of Science ®Google Scholar
• De Schutter A, Kachur S, Lavie CJ, et al. The impact of inflammation on the obesity paradox in coronary artery disease. Int J Obes. 2016;40:1730–1735.
   PubMed Web of Science ®Google Scholar
• Lavie CJ, De Schutter A, Archer E, et al. Obesity and prognosis in chronic diseases-impact of cardiorespiratory fitness in the obesity paradox. Curr Sports Med Rep. 2014;13:349.
   Web of Science ®Google Scholar
• Pandey A, Lavie CJ. Obesity, central adipocity, and fitness: understanding the obesity paradox in the context of other cardiometabolic parameters. Mayo Clin Proc. 2018;93:676–678.
   PubMed Web of Science ®Google Scholar
• Artero EG, Lee D, Lavie CJ, et al. Effects of muscular strength on cardiovascular risk factors and prognosis. J Cardiopulm Rehabil. 2012;32:351–358.
   Google Scholar
• Tan XF, Shi JX, Chen MH. Prolonged and intensive medication use are associated with the obesity paradox after percutaneous coronary intervention: a systematic review and meta-analysis of 12 studies. BMC Cardiovasc Dis. 2016;16:125.
   PubMed Web of Science ®Google Scholar
• Lavie CJ, Deedwania P, Ortega FB. Obesity is rarely healthy. Lancet Diabetes Endocrinol. 2018;6:678–679.
   PubMed Web of Science ®Google Scholar
• Kennedy SN, Lavie CJ, Blair SN. Fitness or fatness. JAMA. 2018;319:231–232.
   PubMed Web of Science ®Google Scholar
• McAuley PA, Keteyian SJ, Brawner CA, et al. Exercise capacity and the obesity paradox in heart failure: the FIT (Henry Ford exercise testing) project. Mayo Clin Proc. 2018;93:701–708.
   PubMed Web of Science ®Google Scholar
• Church T. Why obesity should be treated as a disease. Curr Sports Med. 2014;13:205–206.
   PubMed Web of Science ®Google Scholar
• Lavie CJ, Arena R, Alpert MA, et al. Management of cardiovascular diseases in patients with obesity. Nat Rev Cardiol. 2018;15:45–56.
   PubMed Web of Science ®Google Scholar
• Xu H, Cupples A, Stokes A, et al. Association of obesity with mortality over 24 years of weight history. Findings from the Framingham heart study. JAMA Network Open. 2018;1:e184587.
   PubMed Web of Science ®Google Scholar
• Riaz H, Khan MS, Siddiqi TJ, et al. Association between obesity and cardiovascular outcomes. A systematic review and meta-analysis of mendelian randomized studies. JAMA Network Open. 2018;1:e1833788.
   Web of Science ®Google Scholar